Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors

Clinical Cancer Research

Volumn 9, Issue 5, 2003, Pages 1604-1610

  Ermert, Leander ^a,b   Dierkes, Christian ^a   Ermert, Monika ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Inst für Vet Pathologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN D2 SYNTHASE; PROSTAGLANDIN E2 SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTANOID; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME MECHANISM; GENE CONTROL; HORMONE ACTION; HORMONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TUMOR BLOOD FLOW; TUMOR CELL; TUMOR GROWTH;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOENZYME TECHNIQUES; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; LUNG; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; THROMBOXANE-A SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037652234     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Huang, M., Stolina, M., Sharma, S., Mao, J. T., Zhu, L., Miller, P. W., Wollman, J., Herschman, H., and Dubinett, S. M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58: 1208-1216, 1998.
2. Eli, Y., Przedecki, F., Levin, G., Kariv, N., and Raz, A. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo. Biochem. Pharmacol., 61: 565-571, 2001.
3. Sawaoka, H., Tsujii, S., Tsujii, M., Gunawan, E. S., Sasaki, Y., Kawano, S., and Hori, M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest., 79: 1469-1477, 1999.
4. Ermert, M., Merkle, M., Mootz, R., Grimminger, F., Seeger, W., and Ermert, L. Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs. Am. J. Physiol. Lung Cell. Mol. Physiol., 278: 1195-1203, 2000.
5. Needleman, P., Turk, J., Jakschik, B. A., Morrison, A. R., and Lefkowith, J. B. Arachidonic acid metabolism. Annu. Rev. Biochem., 55: 69-102, 1986.
6. Levy, G. N. Prostaglandin H synthase, non-steroidal anti-inflammatory drugs, and colon cancer. FASEB J., 11: 234-247, 1997.
7. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996.
8. Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, M., Edwards, D. A., Flickinger, A. G., Moore, R. J., and Seibert, K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res., 60: 1306-1311, 2000.
9. Eberhardt, C. E., Coffey, R. J., Radhika, A., Giardello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
10. Tucker, O. N., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., and Fahey, T. J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59: 987-990, 1999.
11. Okami, J., Yamamoto, H., Fujiwara, Y., Tsujie, M., Kondo, M., Noura, S., Oshima, S., Nagano, H., Dono, K., Umeshita, K., Ishikawa, O., Sakon, M., Matsuura, N., Nakamori, S., and Monden, M. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin. Cancer Res., 5: 2018-2024, 1999.
12. Higashi, Y., Kanekura, T., and Kanzaki, T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting Cox-2 expression. Int. J. Cancer, 86: 667-671, 2000.
13. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimäki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
14. Smalley, W., and DuBois, R. N. Colorectal cancer and non steroidal anti-inflammatory drugs. Adv. Pharmacol., 39: 1-20, 1997.
15. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
16. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in APCD716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell, 87: 803-809, 1996.
17. Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., and Taketo, M. M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcD716 knockout mice. Nat. Med., 7: 1048-1051, 2001.
18. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
19. Nie, D., Lamberti, M., Zacharek, A., Li, L., Szekeres, K., Tang, K., Chen, Y., and Honn, K. V. Thromboxane A2 regulation of endothelial cell migration, angiogenesis and tumor metastasis. Biochem. Biophys. Res. Commun., 267: 245-251, 2000.
20. Shore, S. A., Austen, K. F., and Drazen, J. M. Eicosanoids and the lung. In: Massaro D. (ed.), Lung Cell Biology. Vol. 41, pp. 1012-1089, New York: M. Dekker, 1989.
21. Form, D. M., and Auerbach, R. PGE2 and angiogenesis. Proc. Soc. Exp. Biol. Med., 172: 214-218, 1983.
22. Hosomi, Y., Yokose, T., Hirose, Y., Nakajima, R., Nagai, K., Nishiwaki, Y., and Ochiai, A. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer, 30: 73-81, 2000.
23. Watkins, D. N., Lenzo, J. C., Segal, A., Garlepp, M. J., and Thompson, P. J. Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer. Eur. Respir. J., 14: 412-418, 1999.
24. Hubbard, W. C., Alley, M. C., McLemore, T. L., Boyd, M. R. Evidence for thromboxane biosynthesis in established cell lines derived from human lung adenocarcinomas. Cancer Res., 48: 2674-2677, 1988.
25. McLemore, T. L., Hubbard, W. C., Litterst, C. L., Liu, M. C., Miller, S., McMahon, N. A., Eggleston, J. C., and Boyd, M. R. Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res., 48: 3140-3147, 1988.
26. Khuri, F. L., Wu, H., Lee, J. L., Kemp, B. L., Lotan, R., Lippman, S. M., Feng, L., Hong, W. K., and Xu, X. C. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res., 7: 861-867, 2001.
27. Ermert, L., Ermert, M., Goppelt-Struebe, M., Walmrath, D., Grimmiger, F., Steudel, W., Ghofrani, H. A., Homberger, C., Duncker, H. R., and Seeger, W. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am. J. Respir. Cell Mol. Biol., 18: 479-488, 1998.
28. Tsujii, M., Kuwano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
29. Tsujii, M., Kawano, S., Tsujii, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
30. Ben-Av, P., Crofford, L. J., Wilder, R. L., and Hla, T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett., 372: 83-87, 1995.
31. Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., DuBois, R. N., and Breyer, M. D. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Investig., 94: 2504-2510, 1994.
32. Iseki, S. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem. J., 27: 323-328, 1995.
33. Ermert, L., Ermert, M., Althoff, A., Merkle, M., Grimminger, F., and Seeger, W. Vasoregulatory prostanoid generation proceeds via cyclooxygenase-2 in noninflamed rat lungs. J. Pharm. Exp. Ther., 286: 1309-1314, 1998.
34. Ermert, L., Ermert, M., Merkle, M., Goppelt-Struebe, M., Duncker, H. R., Grimminger, F., and Seeger, W. Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge. Differential regulation in the various types of cells in the lung. Am. J. Pathol., 156: 1275-1287, 2000.
35. Narko, K., Ristimäki, A., MacPhee, M., Smith, E., Haudenschild, C. C., and Hla, T. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression. J. Biol. Chem., 272: 21455-21460, 1997.
36. Uefuji, K., Ichikura, T., Mochizuki, and H. Shinomiya, N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J. Surg. Oncol., 69: 168-172, 1998.
37. Lim, H. Y., Joo, H. J., Coi, J. H., Yi, J. W., Yang, M. S., Cho, D. Y., Kim, H. S., Nam, D. K., Lee, K. B., and Kim, H. C. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res., 6: 519-525, 2000.
38. Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D. G., and Mukhtar, H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate, 42: 73-78, 2000.
39. Mestre, J. R., Chan, G., Zhang, F., Yang, E. K., Sacks, P. G., Boyle, J. O., Shah, J. P., Edelstein, D., Subbaramaiah, K., and Dannenberg, A. J. Inhibition of cylcloocygenase-2 expression. An approach to preventing head and neck cancer. Ann. N. Y. Acad. Sci., 889: 62-71, 1999.
40. Ryu, H. S., Chang, K. H., Yang, H. W., Kim, M. S., Kwon, H. C., and Oh, K. S. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol. Oncol., 76: 320-325, 2000.
41. Doré, M., Coté, L. C., Mitchell, A., and Sirois, J. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J. Histochem. Cytochem., 46: 77-84, 1998.
42. Casibang, M., Purdom, S., Jakolew, S., Neckers, L., Zia, F., Ben-Av, P., Hla, T., You, L., Jablons, D. M., and Moody, T. W. Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer, 31: 203-212, 2001.
43. Lynch, P. M. Cox-2 inhibition in clinical cancer prevention. Oncology, 15: 21-26, 2001.
44. Patrono, C., Patrignani, P., and Rodriguez, L. A. G. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J. Clin. Investig., 108: 7-13, 2001.
45. Yoshimatsu, K., Altorki, N. K., Golijanin, D., Zhang, F. K., Jakobson, P. J., Dannenberg, A. J., and Subbaramaiah, K. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res., 9: 2669-2674, 2001.
46. Pepper, M. S., Mandriota, S. J., Vassalli, J. D., Orci, L., and Montesano, R. Angiogenesis-regulating cytokines: activities and interactions. Curr. Top. Microbiol. Immunol., 213: 31-67, 1996.
47. Dormond, O., Foletti, A., Paroz, C., and Ruegg, C. NSAIDs inhibit aVb3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat. Med., 7: 1041-1047, 2001.
48. Ferreri, N. R., Sarr, T., Askenase, P. W., and Ruddle, N. H. Molecular regulation of tumor necrosis factor-α and lymphotoxin production in T cells. Inhibition by prostaglandin E2. J. Biol. Chem., 267: 9443-9449, 1992.
49. Vaillier, D., Daculsi, R., Gualde. N., and Bezian, J. H. Effect of LTB4 on the inhibition of natural cytotoxic activity by PGE2. Cell Immunol., 139: 248-258, 1992.
50. Hubbard, W. C., Alley, M. C., Gray, G. N., Green, K. C., McLemore, T. L., and Boyd, M. R. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors. Cancer Res., 49: 826-832, 1989.
51. Kikuchi, Y., Miyauchi, M., Oomori, K., Kita, T., Kizawa, I., and Kato, K. Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. Cancer Res., 46: 73364-73366, 1986.
52. Needleman, P., Moncada, S., Bunting, S., Vane, J. R., Hamberg, M., and Samuelsson, B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature (Lond.), 261: 558-560, 1976.
53. Ellis, E. F., Oelz, O., Roberts, L. J., Payne, N. A., Sweetman, B. J., Nies, A. S., and Oates, J. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (Wash. DC), 193: 1135-11357, 1976.
54. Hunt, J. A., Merrit, J. E., MacDermot, J., and Keen, M. Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells. Biochem. Pharmacol., 43: 1747-1752, 1992.
55. Pinedo, H. M., Verheul, H. M. W., D'Amato, R. J., and Folkman, J. Involvement of platelets in tumour angiogenesis? Lancet, 352: 1775-1777, 1998.
56. Bing, R. J., Miyataka, M., Rich, K. A., Hanson, N., Wang, X., Slosser, H. D., and Shi, S. R. Nitric oxide, prostanoids, cyclooxygenase and angiogenesis in colon and breast cancer. Clin. Cancer Res., 7: 3385-3392, 2001.